Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Finance · ·
$29.80
▲ $0.22 (+0.7%)
Market data updated: 09/20 03:47 AM
Fundamentals updated: 09/20/2026
News analyzed: 09/20/2026
Market Cap
$1.17B
Day Range
$28.85 - $29.89
52-Week Range
$15.62 - $30.60
Beta
—
Next Earnings
15.10.2026
Support
$24.93
Resistance
$30.60
+40.0% (1Y)
Strengths: 14/22 factors positiveRisk: High
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🟢 Bullish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
DCF Fair Value
Estimated fair value: $57.77 vs. price $29.80 (+93.9%)
Fair Value
Biggest negative driver
Calmar Ratio (return vs. drawdown)
Calmar: 0.47 (3y annualized return 17.7% / max drawdown 37.9%)
Risk
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 2 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 2
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
63
Today
—
30D
—
90D
—
1Y
🕰️ Signal Timeline
What StockIQ actually saw for this stock, and what happened after each signal — real data, not a forecast.
11d ago · $29.68
Evidence: FOMO score jumped from 0 to 30 day-over-day
What happened after
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
74
Quality
No data available
Value
62
Momentum
88
Risk
42
Sentiment
32
Fundamental
46
Institutional
No data available
Stocks with a similar DNA right now
Not enough comparably-scored stocks yet to show similar matches.
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Recent media coverage of Amerant Bancorp Inc. (AMTB) has centered on its financial performance and market perception, with mixed analyst reactions. The company has reported growth in deposits and loans, particularly through international expansion, including Venezuelan customers. However, Stephens & Co. downgraded its rating from Overweight to Equal-Weight, while other analysts like Keefe, Bruyette & Woods raised their price target. Additionally, Amerant’s community-driven earthquake relief efforts in Venezuela were highlighted, reflecting its regional engagement.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about Amerant Bancorp Inc.. News trend score: 32. Reason: 10 of the last 20 articles are negative, versus 7 positive.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
30
🎯 Conviction (vs. Emotion)
50
Psychology
46
Fundamentals
46
Technical
88
Valuation
62
The price is holding at a real, documented historical support/resistance level (a 50-day high or low).
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
Extreme momentum, price far above its moving average, and a large premium over fair value.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
The price rise has far outpaced the actual improvement in fundamental data.
Price (3M)
+26%
Market Narrative
30
Fundamental Reality
50
Narrative Gap
-20
🧠 StockIQ Psychologist
Market behavior suggests a mixed but cautious psychology, with anchoring near resistance (3.1% below) and herd-driven underperformance relative to peers. The narrative gap (-14) hints at a disconnect where fundamentals (realityScore 50) outpace investor narratives (36), yet euphoria remains muted by valuation (-49% vs. DCF). Overconfidence is absent despite momentum alignment, implying traders may be cautious about overpaying. The key question: will traders break resistance or double down on anchoring as peers outperform?
Updated: 09/09/2026, 03:10 AM
What could change this?
👥 What the crowd believes
"Price target increased by 23.79% to 32.51"
"Downgrades Amerant Bancorp from Overweight to Equal-Weight"
"Deposit and loan growth driven by international expansion, with Venezuelan customers"
"Why Amerant Bancorp (AMTB) Might be Well Poised for a Surge"
🧠 Market Brain events driving this
📈 8D Investor Psychology
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Peter Lynch — 100/100
🔴 Weakest match
Samuel Armstrong Nelson — 12/100
🗣️ Why do they disagree?
Based on the documented principles of each investor, the model estimates that Fisher, Lynch, and Smith all assign a perfect score of 100, but Fisher and Smith cite insufficient fundamentals or dividend data while Lynch sees a growth story whose price has not yet caught up. The mid‑range scores from Housel, Mackay, Marks, and Graham (63) suggest a quiet compounder with reasonable risk and no obvious crowd mania, reflecting a more balanced view of risk and valuation. In contrast, the lower scores from Livermore, Bagehot, Loeb, the Marks market‑cycle view, the efficient‑market argument, Veblen, Schwager, Graham’s enterprising criteria, and Nelson highlight concerns such as lack of clear trend, insufficient balance‑sheet data, moderate risk, weak evidence versus an index, and an overbought cycle. These differences arise because each methodology weights growth potential, data availability, risk tolerance, and market efficiency differently, leading some to view AMTB as a possible growth candidate while others advise staying out.
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🟢 100
Not enough fundamentals data for a real Fisher read
Key question
How exceptional is this business, really?
⚠️ Partial data for this stock — score is less reliable — Data availability: 20%
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🟢 100
Growth candidate — the price hasn't caught up to the growth
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟢 100
Not enough dividend/growth data for a real Smith read
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
⚠️ Partial data for this stock — score is less reliable — Data availability: 25%
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🟢 70
The kind of quiet compounder a patient holder could actually stick with
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 68
Some signs of crowd excitement building
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟢 65
Risk appears reasonably priced — no obvious cycle-timing red flag
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟡 63
Mixed — doesn't clearly pass Graham's tests
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🟡 58
No clear trend — Livermore preferred to stay out of this
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟡 57
Somewhere in the middle of the cycle
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🟡 50
Not enough balance-sheet data for a real Bagehot read
Key question
Does this company have enough liquidity to survive real stress?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟡 46
Moderate risk to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 37
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🔴 35
Pattern Veblen would flag as growth pursued for its own sake
Key question
Is management building real value, or just building itself?
⚠️ Partial data for this stock — score is less reliable — Data availability: 45%
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🔴 29
No real setup here — the discipline Schwager's wizards shared would say stay out
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🔴 25
Not statistically cheap enough for the Enterprising Investor's looser safety bar
Key question
Is the stock statistically cheap enough to justify the extra risk?
⚠️ Partial data for this stock — score is less reliable — Data availability: 45%
Fact → Principle → Simulation
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🔴 12
Cycle looks stretched toward overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Based on the last 280 trading days, calculated from real price data. Click an indicator for details and a chart.
🟢 Most indicators support an uptrend (10 bullish · 1 bearish · 1 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear uptrend with no defined trading range in the period examined.
Medium confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
—
Operating Margin
—
Net Margin
—
EBITDA Margin
—
ROE
5.6%
ROA
0.5%
ROIC
—
EPS
$1.26
Cash
$470.15M
Total Debt
—
Current Ratio
—
Debt/Equity
—
אין נתונים היסטוריים זמינים.
Total dividend per share paid each year, over the last 5 years.
| Ex-Dividend Date | Amount per Share |
|---|---|
| 14.8.2026 | $0.090 |
| 15.5.2026 | $0.090 |
| 14.5.2026 | $0.090 |
| 13.2.2026 | $0.090 |
| 12.2.2026 | $0.090 |
| 14.11.2025 | $0.090 |
| 13.11.2025 | $0.090 |
| 15.8.2025 | $0.090 |
| 14.8.2025 | $0.090 |
| 15.5.2025 | $0.090 |
| 14.5.2025 | $0.090 |
| 14.2.2025 | $0.090 |
How is Fair Value calculated? →
Current Price
$29.80
Estimated Fair Value (DCF)
$57.77
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
+93.9%
🟢 Appears cheap relative to estimated value
Year 1 Growth Rate
10.0%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | 10.0% | $142.16M | $130.42M |
| 2 | 8.1% | $153.71M | $129.37M |
| 3 | 6.3% | $163.32M | $126.11M |
| 4 | 4.4% | $170.46M | $120.76M |
| 5 | 2.5% | $174.72M | $113.56M |
Base FCF (last actual year)
$129.24M
Terminal Value
$2.76B
Present Value of Terminal Value
$1.79B
Enterprise Value
$2.41B
Net Debt
$0
Equity Value
$2.41B
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
$22.50
Tangible Book Value per Share (Tangible NAV)
$22.04
Sentiment based on basic keywords (not AI) — 7 positive, 3 neutral, 10 negative out of the last 20 articles.
Yahoo · 18.9.2026
Yahoo · 17.9.2026
Yahoo · 15.9.2026
Yahoo · 14.9.2026
Yahoo · 14.9.2026
Yahoo · 11.9.2026
Zacks · 11.9.2026
Yahoo · 10.9.2026
Zacks · 10.9.2026
SeekingAlpha · 17.8.2026
Zacks · 17.8.2026
Fintel · 12.8.2026
Benzinga · 12.8.2026
GlobeNewswire · 11.8.2026
Zacks · 11.8.2026
SeekingAlpha · 7.8.2026
Fintel · 4.8.2026
Benzinga · 3.8.2026
SeekingAlpha · 1.8.2026
Zacks · 29.7.2026
Amerant Bancorp Inc. (AMTB) currently has a StockIQ AI score of 63/100, rated "Moderate" (a partial score — based on only 6 of 7 categories, some data is currently unavailable). The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
AMTB currently scores 63/100 (Moderate) across the categories we measure (a partial score — based on only 6 of 7 categories, some data is currently unavailable). StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
Per StockIQ's DCF model, AMTB's estimated fair value is $57.77, which is 93.9% above the current price of $29.80. This is one valuation model among several signals in the fair-value category, not a price target.
AMTB's technical score is 88/100, which currently reads as bullish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Estimated fair value: $57.77 vs. price $29.80 (+93.9%); Earnings per share (EPS) growth: 386.4%; Free cash flow growth: 72.8%.
Based on the real signals StockIQ computed: Calmar: 0.47 (3y annualized return 17.7% / max drawdown 37.9%); %K 93.2 — overbought; Return on equity (ROE): 5.6% — weak.
Yes — AMTB has a real recorded dividend payment history on StockIQ. See the Dividends section on this page for the actual per-share amounts and dates.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 0 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| Cragg Lee Ann | Exercise of Derivative Securities | 21.7.2026 | 201 | -201 | — |
| Cragg Lee Ann | Exercise of Derivative Securities | 21.7.2026 | 201 | +201 | — |
| Cragg Lee Ann | Tax Withholding in Shares | 21.7.2026 | 49 | -49 | $25.86 |
| Cragg Lee Ann | Exercise of Derivative Securities | 21.7.2026 | 201 | +201 | — |
| Cragg Lee Ann | Tax Withholding in Shares | 21.7.2026 | 152 | -49 | $25.86 |
| Cragg Lee Ann | Exercise of Derivative Securities | 21.7.2026 | 807 | -201 | — |
| Nursey Michael E. | Exercise of Derivative Securities | 17.6.2026 | 1,343 | -1,343 | — |
| Nursey Michael E. | Exercise of Derivative Securities | 17.6.2026 | 1,343 | +1,343 | — |
| Nursey Michael E. | Tax Withholding in Shares | 17.6.2026 | 328 | -328 | $23.23 |
| Fleitas Armando | Grant/Award from Employer | 8.6.2026 | 1,093 | +1,093 | — |
| Fleitas Armando | Grant/Award from Employer | 8.6.2026 | 1,093 | +1,093 | — |
| Wilson Millar | Grant/Award from Employer | 2.6.2026 | 2,885 | +2,885 | — |
| Marturet M. Gustavo | Grant/Award from Employer | 2.6.2026 | 2,885 | +2,885 | — |
| Lutoff-Perlo Lisa | Grant/Award from Employer | 2.6.2026 | 2,885 | +2,885 | — |
| KOPNISKY JACK L | Grant/Award from Employer | 2.6.2026 | 2,885 | +2,885 | — |
| Rucker Ashaki | Grant/Award from Employer | 2.6.2026 | 2,885 | +2,885 | — |
| Suarez Oscar | Grant/Award from Employer | 2.6.2026 | 2,885 | +2,885 | — |
| Knight Erin D. | Grant/Award from Employer | 2.6.2026 | 2,885 | +2,885 | — |
| Almeida Odilon | Grant/Award from Employer | 2.6.2026 | 2,885 | +2,885 | — |
| Quill John Walton | Grant/Award from Employer | 2.6.2026 | 2,885 | +2,885 | — |
| MORRISON PATRICIA | Grant/Award from Employer | 2.6.2026 | 2,885 | +2,885 | — |
| MORRISON PATRICIA | Grant/Award from Employer | 2.6.2026 | 2,885 | +2,885 | — |
| KOPNISKY JACK L | Grant/Award from Employer | 2.6.2026 | 2,885 | +2,885 | — |
| Lutoff-Perlo Lisa | Grant/Award from Employer | 2.6.2026 | 2,885 | +2,885 | — |
| Almeida Odilon | Grant/Award from Employer | 2.6.2026 | 2,885 | +2,885 | — |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
1,684,308 shares short as of 2026-08-31 · vs. 1,503,570 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
69.8% of trading volume this week was short selling, vs. 68.1% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology